Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 2753

The newly upgraded Linac Coherent Light Source (LCLS) X-ray free-electron laser (XFEL) at the Department of Energy’s SLAC National Accelerator Laboratory successfully produced its first X-rays, and researchers around the world are already lined up to kick off an ambitious science program.

The upgrade, called LCLS-II, creates unparalleled capabilities that will usher in a new era in research with X-rays.

Scientists will be able to examine the details of quantum materials with unprecedented resolution to drive new forms of computing and communications; reveal unpredictable and fleeting chemical events to teach us how to create more sustainable industries and ; study how carry out life’s functions to develop new types of pharmaceuticals; and study the world on the fastest timescales to open up entirely new fields of scientific investigation.

Read more | >

Year 2022 😗😁

During the IEEE International Electron Devices Meeting (or IEDM), Intel claimed that by 2030, there would be circuits with transistor counts of a trillion, roughly ten times the number of transistors currently available on modern CPUs.

At the meeting, Intel’s Components Research Group laid down its prediction for the future of circuits manufacturing (via sweclockers) and how new packaging technologies and materials will allow chipmakers to build chips with 10x the transistor density, keeping in Moore’s Law.

Read more | >

Pediatric specialists at Lucile Packard Children’s Hospital Stanford are implementing innovative uses for immersive virtual reality (VR) and augmented reality (AR) technologies to advance patient care and improve the patient experience.

Through the hospital’s CHARIOT program, Packard Children’s is one of the only hospitals in the world to have VR available on every unit to help engage and distract patients undergoing a range of hospital procedures. Within the Betty Irene Moore Children’s Heart Center, three unique VR projects are influencing medical education for congenital heart defects, preparing patients for procedures and aiding surgeons in the operating room. And for patients and providers looking to learn more about some of the therapies offered within our Fetal and Pregnancy Health Program, a new VR simulation helps them understand the treatments at a much closer level.

Read more | >

Jellyfish are more advanced than once thought. A new study from the University of Copenhagen has demonstrated that Caribbean box jellyfish can learn at a much more complex level than ever imagined—despite only having one thousand nerve cells and no centralized brain. The finding changes our fundamental understanding of the brain and could enlighten us about our own mysterious brains.

After more than 500 million years on Earth, the immense evolutionary success of is undeniable. Still, we’ve always thought of them as simple creatures with very limited learning abilities.

The prevailing opinion is that more advanced nervous systems equate with more advanced learning potential in animals. Jellyfish and their relatives, collectively known as cnidarians, are considered to be the earliest living animals to develop nervous systems and to have fairly simple nervous systems and no centralized brain.

Read more | >

Discovering And Developing Medicines To Keep You Biologically Young — Dr. Marco Quarta, Ph.D. — Co-Founder and CEO, Rubedo Life Sciences; CEO, Phaedon Institute.

Dr. Marco Quarta, Ph.D. is Co-Founder and CEO of Rubedo Life Sciences (https://www.rubedolife.com/), a biopharmaceutical company developing a broad portfolio of innovative therapies engineered to target cells which drive chronic age-related diseases. The company’s proprietary ALEMBIC™ drug discovery platform has engineered novel first-in-class small molecules designed to selectively target senescent cells, which play a key role in the progression of pulmonary, dermatological, oncological, neurodegenerative, fibrotic and other chronic disorders.

Dr. Quarta received his doctorate degree in Biotechnology from the University of Bologna and a Ph.D. in Neuroscience from the University of Padua. He completed a post-doc in Aging and Stem cell Biology in the lab of Prof. Thomas Rando at Stanford University and continued his work at Stanford directing a research team at the Center for Tissue Regeneration, Repair, and Restoration at the VA Hospital in Palo Alto, CA. While there, he established a translational program in regenerative medicine. He has over 35 publications and patents in the field of aging, stem cells, regenerative medicine, and rejuvenation.

Continue reading “Dr. Marco Quarta, Ph.D. — Co-Founder and CEO — Rubedo Life Sciences; CEO, The Phaedon Institute” | >

Fascinating… when can we expect this to be invented?

A short film set in the near future, where augmented reality has become so ubiquitous that the line between the real and virtual worlds have become blurred. When a new, dangerous technology is created that can manipulate the perception of this brave new world, who will exploit it? Who will monetize it? Who will become twisted by it?

“Augmented” by Ross Peacock.

Continue reading “Sci-Fi Short Film “Augmented” | DUST | Flashback Friday” | >

Waymo is offering some Los Angeles residents the chance to ride in the self-driving car across the city.

The company is kicking off its Waymo One tour, which they say is ‘the world’s first fully autonomous ride-hailing service,’ in October.

“Chauffeured by the Waymo Driver — Waymo’s autonomous driving technology that never gets distracted, drowsy or drunk — Angelenos will discover new and stress-free ways to explore their city, whether it’s finding hidden gem thrift spots in Mid City, trying a new cafe in Koreatown or catching a concert in DTLA,” the company said.

Read more | >

Scientists from IOCB Prague are the first to describe the causes of the behavior of one of the fundamental aromatic molecules, azulene. This molecule has captivated the scientific community not just with its distinct blue hue, but also with its unique properties.

Their current undertaking will influence the foundations of organic chemistry in the years to come and in practice will help harness the maximum potential of captured light energy. Their findings were recently published in the Journal of the American Chemical Society (JACS).

Azulene has piqued the curiosity of chemists for many years. The question of why it is blue, despite there being no obvious reason for this, was answered almost fifty years ago by a scientist of global importance, who, coincidentally, had close ties with IOCB Prague, Prof. Josef Michl.

Read more | >